- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.11. | Guardian Pharmacy Services stock price target raised by Raymond James | 6 | Investing.com | ||
| 12.11. | Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast | 1 | MarketBeat | ||
| 11.11. | Why Guardian Pharmacy Services Stock Was on a Tear Tuesday | 1 | The Motley Fool | ||
| 10.11. | Starkes drittes Quartal: Guardian Pharmacy Services erhöht Jahresprognose | 3 | Investing.com Deutsch | ||
| 10.11. | Guardian Pharmacy Services, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 10.11. | Guardian Pharmacy Services, Inc. - 8-K, Current Report | - | SEC Filings | ||
| GUARDIAN PHARMACY SERVICES Aktie jetzt für 0€ handeln | |||||
| 14.10. | Guardian Pharmacy Services files shelf registration statement | 1 | Investing.com | ||
| 14.10. | Guardian Pharmacy Services reicht Shelf-Registrierung ein | 1 | Investing.com Deutsch | ||
| 14.10. | Guardian Pharmacy Services, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.10. | Guardian Pharmacy files to sell 1.02M shares of Class A common stock | 2 | Seeking Alpha | ||
| 10.10. | Oppenheimer initiates Guardian Pharmacy stock with Outperform rating | 1 | Investing.com | ||
| 10.10. | Oppenheimer startet Coverage für Guardian Pharmacy mit "Outperform" | 1 | Investing.com Deutsch | ||
| 26.09. | Guardian Pharmacy Services stock price target raised to $30 at Truist | 3 | Investing.com | ||
| 18.09. | Guardian Pharmacy Services, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 11.08. | Guardian Pharmacy Services, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 11.08. | Guardian Pharmacy Services, Inc. - 8-K, Current Report | 1 | SEC Filings |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTELLIGENT BIO SOLUTIONS | 9,530 | +126,37 % | INBS partners with Syrma Johari to boost production, improve margins | ||
| BETA BIONICS | 30,470 | -4,66 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 130,06 | +1,53 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,920 | +0,54 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| HEARTFLOW | 29,150 | -3,51 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,760 | +0,37 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 48,980 | +0,60 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,760 | +2,70 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,170 | -2,85 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,000 | -1,57 % | EILMELDUNG: Carl Zeiss Meditec-Aktie tritt auf der Stelle - Anleger warten auf das nächste Signal. | ||
| SIGHT SCIENCES | 7,930 | -0,88 % | Sight Sciences, Inc.: Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer | MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,450 | -0,56 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| OPTIMIZERX | 12,260 | -1,01 % | OptimizeRx Corporation: OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising | Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept.... ► Artikel lesen | |
| CERIBELL | 21,930 | +1,01 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| EKSO BIONICS | 8,640 | -18,34 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen |
GUARDIAN PHARMACY SERVICES INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,095 (-0,32 %) liegt der Kurs bei 30,065 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GUARDIAN PHARMACY SERVICES INC finden Sie auf Wallstreet Online.